Ambaic, Yolando T.
HRN: 07-52-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
CEFUROXIME 750MG (VIAL)
07/25/2024
08/01/2024
IV
1.5g
Q8hrs
Elective Herniorrhaphy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes